EE200200493A - Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon - Google Patents

Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon

Info

Publication number
EE200200493A
EE200200493A EEP200200493A EEP200200493A EE200200493A EE 200200493 A EE200200493 A EE 200200493A EE P200200493 A EEP200200493 A EE P200200493A EE P200200493 A EEP200200493 A EE P200200493A EE 200200493 A EE200200493 A EE 200200493A
Authority
EE
Estonia
Prior art keywords
preparation
delivery system
composition containing
pharmaceutical composition
lipid delivery
Prior art date
Application number
EEP200200493A
Other languages
English (en)
Estonian (et)
Inventor
Fischer Andreas
Adde Christina
Herslf Bengt
Original Assignee
Lipocore Holding Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipocore Holding Ab filed Critical Lipocore Holding Ab
Publication of EE200200493A publication Critical patent/EE200200493A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200200493A 2000-03-06 2001-03-05 Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon EE200200493A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000730A SE0000730D0 (sv) 2000-03-06 2000-03-06 Lipid carrier
PCT/SE2001/000461 WO2001066086A1 (en) 2000-03-06 2001-03-05 Lipid carrier

Publications (1)

Publication Number Publication Date
EE200200493A true EE200200493A (et) 2003-12-15

Family

ID=20278702

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200493A EE200200493A (et) 2000-03-06 2001-03-05 Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon

Country Status (19)

Country Link
US (1) US20030113351A1 (xx)
EP (1) EP1261319A1 (xx)
JP (1) JP2003525892A (xx)
KR (1) KR20030011786A (xx)
CN (1) CN1416334A (xx)
AU (1) AU2001237872A1 (xx)
BR (1) BR0108718A (xx)
CA (1) CA2401889A1 (xx)
CZ (1) CZ20022980A3 (xx)
EE (1) EE200200493A (xx)
HU (1) HUP0300189A2 (xx)
MX (1) MXPA02008270A (xx)
NO (1) NO20024231L (xx)
NZ (1) NZ520616A (xx)
PL (1) PL358616A1 (xx)
RU (1) RU2002126563A (xx)
SE (1) SE0000730D0 (xx)
WO (1) WO2001066086A1 (xx)
ZA (1) ZA200206197B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020318A1 (en) * 2001-09-04 2003-03-13 Lipocore Holding Ab A topical w/o-emulsion composition
SE0102933D0 (sv) * 2001-09-04 2001-09-04 Lipocore Holding Ab Lipid carrier
NZ518997A (en) * 2002-05-16 2004-12-24 Interag Injection formulation for parenteral administration of biodegradable implant for sustained release of active agent
JP2003342196A (ja) * 2002-05-31 2003-12-03 Mukku:Kk 静脈注射用組成物、その製造法およびその製剤
SE0201922D0 (sv) * 2002-06-20 2002-06-20 Ltp Lipid Technologies Provide Koagulationshindrande komposition (Anticoagulant Composition)
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8618056B2 (en) 2007-12-22 2013-12-31 Cuthbert O. Simpkins Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
US8063020B2 (en) * 2007-12-22 2011-11-22 Simpkins Cuthbert O Resuscitation fluid
EP2391341A4 (en) * 2009-01-30 2012-05-09 Cuthbert O Simpkins REVIVAL LIQUID
WO2012054447A2 (en) * 2010-10-22 2012-04-26 Dr. Reddy's Laboratories, Inc. Use of storage stable viscous phospholipid depot to treat wounds
JP6762302B2 (ja) * 2015-08-26 2020-09-30 株式会社明治 コラーゲンペプチド及びセラミドを含有する組成物とその製造方法
CN108498849B (zh) * 2018-05-08 2021-04-30 武汉百纳礼康生物制药有限公司 一种液晶凝胶肝动脉栓塞剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
DE4023045A1 (de) * 1990-07-09 1992-01-16 Swf Auto Electric Gmbh Wischeranlage fuer kraftfahrzeuge
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
SE9200952D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical carrier system containing defined lipids
ES2158084T3 (es) * 1994-02-04 2001-09-01 Lipocore Holding Ab Preparaciones vehiculo lipofilicas.
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation

Also Published As

Publication number Publication date
NO20024231D0 (no) 2002-09-05
US20030113351A1 (en) 2003-06-19
WO2001066086A1 (en) 2001-09-13
KR20030011786A (ko) 2003-02-11
CN1416334A (zh) 2003-05-07
HUP0300189A2 (hu) 2003-09-29
JP2003525892A (ja) 2003-09-02
MXPA02008270A (es) 2004-04-05
BR0108718A (pt) 2002-12-03
AU2001237872A1 (en) 2001-09-17
SE0000730D0 (sv) 2000-03-06
ZA200206197B (en) 2003-11-03
RU2002126563A (ru) 2004-03-20
CZ20022980A3 (cs) 2003-01-15
CA2401889A1 (en) 2001-09-13
PL358616A1 (en) 2004-08-09
NO20024231L (no) 2002-09-05
EP1261319A1 (en) 2002-12-04
NZ520616A (en) 2004-06-25

Similar Documents

Publication Publication Date Title
EE200200046A (et) 8-fenüül-6,9-dihüdro-[1,2,4]triasolo[3,4-i]puriin-5-ooni derivaat, selle valmistamine ja raviotstarbeline kasutamine ning seda sisaldav farmatseutiline kompositsioon
EE05082B1 (et) Pürroolirea ühend, selle valmistamine ja kasutamine lipiidi- ja kolesteroolitaset alandava ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
HUP0302550A3 (en) Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them
IL156531A0 (en) Lipid nanoparticles, their preparation and pharmaceutical compositions containing them
ATE298571T1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
ID22565A (id) Penggunaan nanodispersi dalam formulasi akhir obat
DE60038304D1 (de) Interleukin-12 p40 und interleukin-b30. kombinationen davon. antikörper. verwendungen in pharmazeutische zusammensetzungen
EE05220B1 (et) Bis-arüülühend, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
AU7645701A (en) Cosmetic or pharmaceutical composition in solid form comprising bis-acyl-amides
EE200300240A (et) Arüülitud furaan- ja tiofeenkarboksamiid, seda sisaldav ravimpreparaat ning ühendi kasutamine kaaliumikanali blokaatorina toimiva ravimi valmistamiseks
EE200200522A (et) Toimeainega konjugeerunud ensüüm-lõhustuv peptiid, seda sisaldav farmatseutiline kompositsioon ningühendi kasutamine kasvajavastase ravimina
HUP0204574A3 (en) Propionic acid derivatives and their use in the treatment of diabetes and obesity, pharmaceutical compositions containing them and their preparation
EE04877B1 (et) Asendatud 3-fenl-5-alkoks-1,3,4-oksadiasol-2-oon, selle valmistamine ja kasutamine hormoontundlikku lipaasi p„rssivas ravimis ning seda sisaldav suhkurt?ve ravim
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
EE200200493A (et) Lipiidne kandesüsteem, selle kasutamine ravimpreparaatide valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
EE04955B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
AU2001235442A1 (en) Oral delivery of allergens in milk
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
EE200200057A (et) Kasvutegurit IL-5 pärssiv asauratsiilderivaat, selle saamine ja kasutamine ravimi valmistamiseks ning seda sisaldav farmatseutiline kompositsioon
HUP0204202A3 (en) Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
EE200200199A (et) N-guanidinoalküülamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine
BR0012184B1 (pt) compostos derivados de indol, formulação farmacêutica, e, composição e uso dos compostos na fabricação de medicamentos
EE04811B1 (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim